A Prospective Trial of an Endoscopic Quality Improvement Project

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized prospective multi-site validation study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endoscopic Quality Improvement Program

NCT01415817

Adenomatous Polyps Colorectal Polyps

COMPLETED NA

Detection and Classification of Colon Polyps

NCT00825292

Colon Polyps

COMPLETED PHASE2

Retroview Colonoscope for the Evaluation of Colon Mucosa Study

NCT02352233

Colonic Diseases

COMPLETED

Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies

NCT00874263

Colonic Polyps Esophageal Diseases

COMPLETED

Combined Forward and Retroflexion Withdrawal in the Detection of Polyps and Adenoma During Colonoscopy

NCT03901651

Colonic Polyp Colonic Neoplasms Colonic Adenoma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

GI practice sites that have recently agreed to participate in the GIQuIC program will be randomized on a site-basis, to the EQUIP intervention or control.

Baseline ADR and polyp/surveillance predication accuracy will be collected for approximately 3 months.

Sites randomized to the EQUIP intervention will undergo face-to-face training by a study investigator, followed by active monitoring and feedback.

Control sites will not receive supplemental training and will be monitored by with no feedback. After completion of the study all sites will be offered the intervention (as is standard feedback in GIQuIC ).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Polyps

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Training of Endoscopist

A series of 1 hour classes with ongoing monitoring and feedback to endoscopist only.

Group Type EXPERIMENTAL

Educational Training

Intervention Type OTHER

Intervention/Training offered to endoscopists only.

Deferred Training of Endoscopist

No intervention during the data collection period. Training will be deferred to end of study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational Training

Intervention/Training offered to endoscopists only.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intervention offered to endoscopist only.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Endoscopy centers that are new to GIQuIC and have not yet received training
* All endoscopists performing screening and surveillance colonoscopy at the participating center will be invited to participate

Exclusion Criteria

* Cases that involve acute indications such as bleeding and active colitis will not be included in data pool
* Patients with a family or personal history of a polyposis syndrome or with a personal history of inflammatory bowel disease will also be excluded
* Procedures that are deemed incomplete will be excluded
* Patients with surgically altered anatomy (i.e. prior colectomy) and with poor bowel preparation (Boston bowel preparation score \<5, or inadequate to exclude polyps \>5mm) will be excluded

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes